High intensity focused ultrasound enhances anti-tumor immunity by inhibiting the negative regulatory effect of miR-134 on CD86 in a murine melanoma model

Oncotarget

Volumn 6, Issue 35, 2015, Pages 37626-37637

  Yuan, Shi Mei ^a   Li, Huan ^a   Yang, Min ^a   Zha, He ^a   Sun, Hui ^a   Li, Xue Ru ^a   Li, Ai Fang ^a   Gu, Yue ^a   Duan, Liang ^a   Luo, Jin Yong ^a   Li, Chong Yan ^a   Wang, Yan ^a   Wang, Zhi Biao ^a   He, Tong Chuan ^a,b   Zhou, Lan ^a  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF CHICAGO MEDICAL CENTER   (United States)

Author keywords

Anti tumor immunity; Co stimulatory molecules; HIFU; microRNA

Indexed keywords

CD86 ANTIGEN; GAMMA INTERFERON; MESSENGER RNA; MICRORNA; MICRORNA 134; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; CD86 PROTEIN, HUMAN; MIRN134 MICRORNA, HUMAN;

3' UNTRANSLATED REGION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; B16F10 CELL; CANCER GRAFT; CANCER MODEL; CANCER SURVIVAL; CELL SURVIVAL; CELL VIABILITY; COCULTURE; CONTROLLED STUDY; CYTOKINE RELEASE; DOWN REGULATION; FEMALE; GAMMA INTERFERON BLOOD LEVEL; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; HIGH INTENSITY FOCUSED ULTRASOUND; HISTOPATHOLOGY; IMMUNOREGULATION; IMMUNOSTIMULATION; IN VITRO STUDY; LUNG METASTASIS; LUNG NODULE; MELANOMA; MELANOMA CELL LINE; MOUSE; NONHUMAN; PROTEIN BLOOD LEVEL; RNA ANALYSIS; RNA BINDING; SPLEEN LYMPHOCYTE; THERAPY EFFECT; TUMOR IMMUNITY; TUMOR NECROSIS FACTOR ALPHA BLOOD LEVEL; ANIMAL; ANTAGONISTS AND INHIBITORS; APOPTOSIS; C57BL MOUSE; CELL PROLIFERATION; DIAGNOSTIC IMAGING; DRUG SCREENING; ECHOGRAPHY; EXPERIMENTAL MELANOMA; FLOW CYTOMETRY; GENETICS; HUMAN; IMMUNOLOGY; LUNG TUMOR; METABOLISM; PATHOLOGY; RADIATION RESPONSE; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SECONDARY; TUMOR CELL CULTURE; ULTRASOUND THERAPY; WESTERN BLOTTING;

ANIMALS; ANTIGENS, CD86; APOPTOSIS; BLOTTING, WESTERN; CELL PROLIFERATION; FEMALE; FLOW CYTOMETRY; HUMANS; LUNG NEOPLASMS; MELANOMA, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; ULTRASONIC THERAPY; ULTRASONOGRAPHY; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84947774769     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.5285     Document Type: Article

References (28)

1. Napoli A, Anzidei M, Ciolina F, Marotta E, Cavallo MB, Brachetti G, Di Mare L, Cartocci G, Boni F, Noce V, Bertaccini L, Catalano C. Mr-guided high-intensity focused ultrasound: current status of an emerging technology. Cardiovasc Intervent Radiol. 2013; 36:1190-1203.
2. Jenne JW, Preusser T, Gunther M. High-intensity focused ultrasound: principles, therapy guidance, simulations and applications. Z Med Phys. 2012; 22:311-322.
3. Wu F. High intensity focused ultrasound ablation and antitumor immune response. J Acoust Soc Am. 2013; 134:1695-1701.
4. Haen SP, Pereira PL, Salih HR, Rammensee HG, Gouttefangeas C. More than just tumor destruction: immunomodulation by thermal ablation of cancer. Clin Dev Immunol. 2011; 2011:160250.
5. Huang X, Yuan F, Liang M, Lo HW, Shinohara ML, Robertson C, Zhong P. M-hifu inhibits tumor growth, suppresses stat3 activity and enhances tumor specific immunity in a transplant tumor model of prostate cancer. PLoS One. 2012; 7:e41632.
6. Wu F, Wang ZB, Cao YD, Zhou Q, Zhang Y, Xu ZL, Zhu XQ. Expression of tumor antigens and heat-shock protein 70 in breast cancer cells after high-intensity focused ultrasound ablation. Ann Surg Oncol. 2007; 14:1237-1242.
7. Zhang Y, Deng J, Feng J, Wu F. Enhancement of antitumor vaccine in ablated hepatocellular carcinoma by highintensity focused ultrasound. World J Gastroenterol. 2010; 16:3584-3591.
8. Hu Z, Yang XY, Liu Y, Morse MA, Lyerly HK, Clay TM, Zhong P. Release of endogenous danger signals from hifutreated tumor cells and their stimulatory effects on apcs. Biochem Biophys Res Commun. 2005; 335:124-131.
9. Goronzy JJ, Weyand CM. T-cell co-stimulatory pathways in autoimmunity. Arthritis Res Ther. 2008; 10:S3.
10. Chen L, Flies DB. Molecular mechanisms of t cell co-stimulation and co-inhibition. Nat Rev Immunol. 2013; 13:227-242.
11. Wang LX, Mei ZY, Zhou JH, Yao YS, Li YH, Xu YH, Li JX, Gao XN, Zhou MH, Jiang MM, Gao L, Ding Y, Lu XC, Shi JL, Luo XF, Wang J, Wang LL, Qu C, Bai XF, Yu L. Low dose decitabine treatment induces cd80 expression in cancer cells and stimulates tumor specific cytotoxic tlymphocyte responses. PLoS One. 2013; 8:e62924.
12. Lee HM, Nguyen DT, Lu LF. Progress and challenge of microRNA research in immunity. Front Genet. 2014; 5:178.
13. Monticelli S. Micrornas in T helper cell differentiation and plasticity. Semin Immunol. 2013; 25:291-298.
14. Morris KL, Tugwood JD, Khoja L, Lancashire M, Sloane R, Burt D, Shenjere P, Zhou C, Hodgson C, Ohtomo T, Katoh A, Ishiguro T, Valle JW, Dive C. Circulating biomarkers in hepatocellular carcinoma. Cancer Chemother Pharmacol. 2014; 74:323-332.
15. Smith B, Selby P, Southgate J, Pittman K, Bradley C, Blair GE. Detection of melanoma cells in peripheral blood by means of reverse transcriptase and polymerase chain reaction. Lancet. 1991; 338:1227-1229.
16. Sang M, Wang L, Ding C, Zhou X, Wang B, Wang L, Lian Y, Shan B. Melanoma-associated antigen genes-an update. Cancer Lett. 2011; 302:85-90.
17. Hoshimoto S, Shingai T, Morton DL, Kuo C, Faries MB, Chong K, Elashoff D, Wang HJ, Elashoff RM, Hoon DS. Association between circulating tumor cells and prognosis in patients with stage iii melanoma with sentinel lymph node metastasis in a phase iii international multicenter trial. J Clin Oncol. 2012; 30:3819-3826.
18. Kim J, Taube JM, McCalmont TH, Glusac EJ. Quantitative comparison of mitf, melan-a, hmb-45 and mel-5 in solar lentigines and melanoma in situ. J Cutan Pathol. 2011; 38:775-779.
19. Fusi A, Collette S, Busse A, Suciu S, Rietz A, Santinami M, Kruit WH, Testori A, Punt CJ, Dalgleish AG, Spatz A, Eggermont AM, Keilholz U. Circulating melanoma cells and distant metastasis-free survival in stage iii melanoma patients with or without adjuvant interferon treatment (eortc 18991 side study). Eur J Cancer. 2009; 45:3189-3197.
20. Xia JZ, Xie FL, Ran LF, Xie XP, Fan YM, Wu F. Highintensity focused ultrasound tumor ablation activates autologous tumor-specific cytotoxic t lymphocytes. Ultrasound Med Biol. 2012; 38:1363-1371.
21. Deng J, Zhang Y, Feng J, Wu F. Dendritic cells loaded with ultrasound-ablated tumour induce in vivo specific antitumour immune responses. Ultrasound Med Biol. 2010; 36:441-448.
22. Hu Z, Yang XY, Liu Y, Sankin GN, Pua EC, Morse MA, Lyerly HK, Clay TM, Zhong P. Investigation of hifu-induced anti-tumor immunity in a murine tumor model. J Transl Med. 2007; 5:34.
23. Wu F, Wang ZB, Lu P, Xu ZL, Chen WZ, Zhu H, Jin CB. Activated anti-tumor immunity in cancer patients after high intensity focused ultrasound ablation. Ultrasound Med Biol. 2004; 30:1217-1222.
24. Ford ML, Adams AB, Pearson TC. Targeting co-stimulatory pathways: transplantation and autoimmunity. Nat Rev Nephrol. 2014; 10:14-24.
25. Zang X, Allison JP. The b7 family and cancer therapy: costimulation and coinhibition. Clin Cancer Res. 2007; 13:5271-5279.
26. Lebedeva T, Dustin ML, Sykulev Y. Icam-1 co-stimulates target cells to facilitate antigen presentation. Curr Opin Immunol. 2005; 17:251-258.
27. Unga J, Hashida M. Ultrasound induced cancer immunotherapy. Adv Drug Deliv Rev. 2014; 72:144-153.
28. Zhu XY, Zhou YH, Wang MY, Jin LP, Yuan MM, Li DJ. Blockade of cd86 signaling facilitates a th2 bias at the maternal-fetal interface and expands peripheral cd4+cd25+ regulatory t cells to rescue abortion-prone fetuses. Biol Reprod. 2005; 72:338-345.